Видео ютуба по тегу Community Oncology

Cancer Education Series: Cancer Support Community!
Cancer Education Series: Cancer Support Community!
Management of Bladder Cancer: Insights from Community Practice w/ Dr. Gautam Jayram | URO Ep. 209
Management of Bladder Cancer: Insights from Community Practice w/ Dr. Gautam Jayram | URO Ep. 209
HER2 Treatment Strategies: Dr. Matthew Kurian & Dr. Giuseppe Curigliano at Oncology Brothers Event
HER2 Treatment Strategies: Dr. Matthew Kurian & Dr. Giuseppe Curigliano at Oncology Brothers Event
Myeloma: Real-World Use of Bispecific Antibodies in Community Oncology | Lisa Herms, PhD | #ASH24
Myeloma: Real-World Use of Bispecific Antibodies in Community Oncology | Lisa Herms, PhD | #ASH24
MCL updates from ASH 2024 and the key takeaways for community oncologists
MCL updates from ASH 2024 and the key takeaways for community oncologists
Leading the way: Evidence-based community oncology cancer care by Dr. Joni Watson
Leading the way: Evidence-based community oncology cancer care by Dr. Joni Watson
Addressing Barriers in Advancing Equitable Biomarker Testing in Community Oncology
Addressing Barriers in Advancing Equitable Biomarker Testing in Community Oncology
Addressing Barriers in Advancing Equitable Biomarker Testing in Community Oncology
Addressing Barriers in Advancing Equitable Biomarker Testing in Community Oncology
How to Approach to Ovarian Cancer from Community Oncology Perspective
How to Approach to Ovarian Cancer from Community Oncology Perspective
The Value of Community Oncology
The Value of Community Oncology
CPAN Advocates in Action
CPAN Advocates in Action
The Benefits of In-House Pharmacies
The Benefits of In-House Pharmacies
How to Approach to Endometrial Cancer from Community Oncology Perspective
How to Approach to Endometrial Cancer from Community Oncology Perspective
The Role of Pharmacists in Community Oncology: A CPAN Advocacy Chat
The Role of Pharmacists in Community Oncology: A CPAN Advocacy Chat
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
Addressing the need for biomarkers in community oncology practice
Addressing the need for biomarkers in community oncology practice
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
Revolutionizing Patient Care: The Community Oncology Approach
Revolutionizing Patient Care: The Community Oncology Approach
Revolutionizing Patient Care: The Community Oncology Approach
Revolutionizing Patient Care: The Community Oncology Approach